2 Minute Medicine Rewind February 1, 2016
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia BCL2 is an anti-apoptotic protein that allows chronic lymphocytic leukemia cells ...
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia BCL2 is an anti-apoptotic protein that allows chronic lymphocytic leukemia cells ...
Mass Drug Administration for Scabies Control in a Population with Endemic Disease Scabies is an underrecognized and common disease ...
1. HIV-1 acquisition rates were significantly lower in men who used tenofovir-disoprovil fumarate (TDF) and emtricitabine (FTC) preexposure prophylaxis (PrEP). ...
Home Use of an Artificial Beta Cell in Type 1 Diabetes While intensive insulin therapy is the standard of care ...
1. This randomized controlled trial showed that prophylaxis with lopinavir-ritonavir was not superior to lamivudine in preventing HIV infections through breastfeeding ...
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia BRAF V600E has been identified as the genetic lesion responsible for ...
1. In this randomized open-label trial, pre-exposure prophylaxis (PrEP) with once daily tenofovir-emtricitabine was found effective in preventing HIV-1 infection ...
1. Almost 75% of HIV-infected adults in the USA received medical and support services from a Ryan-White HIV/AIDS funded facility. ...
1. Asymptomatic, HIV-positive adults with CD4 cell counts above 500 who were initiated on antiretroviral therapy (ART) immediately had significantly ...
1. In a retrospective review of a large cancer database of over 1.8 million patients, HIV infection was associated with ...
5-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Monthly plan selected: $4.99 /month.
5-day free trial · cancel anytime
Then $4.99/month. Manage renewal in your account.
Yearly plan selected: $49.90 /year.
2 months free · only $4.16/month
Then $49.90/year. Manage renewal in your account.
Already a member? Sign in